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Abstract
Objectives: This study was conducted to evaluate the added value of an enhanced recovery after
surgery (ERAS) programme in laparoscopic liver resections for solid tumours.
Methods: Patients undergoing laparoscopic liver resection between July 2005 and July 2008 were
included. Indications for resections included presumed benign and malignant liver lesions. Primary
outcome was total length of hospital stay (LOS). Secondary outcomes were functional recovery, compli-
cations, conversions, blood loss and duration of operation.
Results: Thirteen patients were treated by laparoscopic liver resections in the ERAS programme in one
centre (group 1). Their outcomes were compared with outcomes of 13 laparoscopic procedures per-
formed either before the introduction of the ERAS programme during 2003–2005 in the same centre or
during the same period in other centres using traditional care (group 2). Median total LOS was 5.0 days
(range 3–10 days) in group 1 and 7.0 days (3–12 days) in group 2. This difference was not statistically
significant. Functional recovery occurred 2 days earlier in group 1 (median 3.0 days [range 1–7 days] vs.
median 5.0 days [range 2–8 days]; P < 0.044). There were no significant differences in complications,
conversions or duration of operation. Blood loss was significantly less in the ERAS group (median 50 ml
[range 50–200 ml] vs. median 250 ml [range 50–800 ml]; P < 0.002).
Conclusions: This exploratory, multicentre, fast-track laparoscopic liver resection study is the first such
study conducted. Although small, the study suggests that a multimodal enhanced recovery programme
in laparoscopic liver surgery is feasible, safe and may lead to accelerated functional recovery and
reductions in LOS.
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Introduction
Laparoscopic surgical procedures have been popularized because
they allow for rapid recovery, shorter postoperative hospital stays
and improved cosmetic outcomes. In gastrointestinal surgery, the
minimally invasive approach is extensively used in many opera-
tions and has become the gold standard for some of these proce-
dures, such as cholecystectomy and adrenalectomy.1,2 For solid
tumours in the liver, the laparoscopic technique is used more and
more frequently in expert centres and the results, mostly from
cohort studies, suggest benefits, notably in terms of shorter post-
operative stays.3 With respect to improved recovery and outcome,
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a multimodal enhanced recovery after surgery (ERAS) pro-
gramme has recently shown promising results in many open elec-
tive colorectal operations, as well as in liver surgery.4,5 This
multimodal recovery programme is evidence-based and combines
several interventions in perioperative care to reduce the stress
response and organ dysfunction, with a focus on enhancing recov-
ery.5,6 The key elements of this protocol include the provision
of preoperative counselling, perioperative i.v. fluid restriction,
optimal pain relief, preferably without the use of opioid analgesia,
early oral nutrition and enforced mobilization, and the absence of
nasogastric tubes and drains.6–8 In other fields of elective surgery,
similar programmes have been shown to reduce hospital stay by
several days.9,10 However, to our knowledge, the added value of a
fast-track ERAS programme in laparoscopic liver surgery has
hitherto not been explored. At the Maastricht University Medical
Centre (MUMC), the ERAS programme for liver surgery started 2
years after the laparoscopic programme for left lateral sectionec-
tomies. Therefore, a pilot study was conducted to find out whether
the ERAS programme was feasible and safe and whether it
improved recovery after laparoscopic liver surgery.
Materials and methods
Patients undergoing laparoscopic liver resections for solid liver
tumours between July 2003 and July 2008 were enrolled in the
study. Preoperative assessment consisted of standard plasma liver
function tests, preoperative radiological evaluation with abdomi-
nal ultrasonography, contrast-enhanced computed tomography
(CT) and/or selective magnetic resonance imaging (MRI) and/or
CT-positron emission tomography (CT-PET). Multidisciplinary
consent was also required. All lesions <10 cm in diameter and
judged amenable to laparoscopic resection were included (left
lateral sectionectomy or anterolateral small lesions of the right side
of the liver).All but one lesionwere limited to lateral liver segments
(II, III, V, VI). One lesion was located centrally in segment IV.
Indications for surgery included presumed benign and malignant
liver lesions. For patients with presumed benign disease, the indi-
cations were suspicion of a hepatocellular adenoma or cystad-
enoma or, in cases where the nature of the tumour was uncertain,
the presence of symptoms and risk of bleeding. Indications for liver
metastaseswere synchronous ormetachronous liver tumours from
colorectal malignancies. Patients were informed about the opera-
tive procedure and consent was obtained.
The ERAS perioperative programme was instituted in the sur-
gical unit in Maastricht at the beginning of 2002, initially for
patients undergoing elective colonic resections.11 The protocol for
this multimodal, evidence-based, enhanced recovery programme
for colonic surgery requires extensive preoperative counselling,
no premedication, no preoperative fasting but carbohydrate-
containing liquids until 2 hours before surgery, mid-thoracic epi-
dural anaesthesia and short-acting anaesthetics, perioperative
oxygen supplementation, avoidance of perioperative fluid over-
load, non-opioid pain management, no routine use of nasogastric
tubes, early removal of bladder catheters, standard laxatives and
prokinetics, and early and enhanced postoperative feeding and
mobilization.5,11 This protocol was modified in 2005 to cover all
aspects of liver surgery, including laboratory liver function tests,
and to avoid excessive fluids (preoperative and perioperative
central venous pressure [CVP] <5 mmHg).4
Until May 2005, traditional care was given before, during and
after liver surgery. Therefore, the 5-year period during which lap-
aroscopic liver surgery for solid tumours has been performed at
MUMC was divided into two periods, representing the 2 years
before the ERAS programme was implemented and the 3 years
immediately following its implementation. As the number of
patients in theMUMCcontrol group (patients undergoing surgery
with traditional perioperative care) was too small to allow us to
draw firm conclusions, other major liver centres in the Nether-
lands, which were not familiar with the ERAS programme and
which applied a traditional care protocol, were contacted in order
to enrol additional laparoscopic liver resection patients. These
included the Academic Medical Centre (AMC), Amsterdam, the
University Medical Centre Utrecht (UMCU), Utrecht, and the
University Medical Centre Groningen (UMCG), Groningen.
The following recovery data were defined (and patients were
considered functionally recovered when all criteria were met):
normal or decreasing serum bilirubin; good pain control on oral
analgesics only; absence of i.v. fluids and tolerance of solid food,
and mobilization to preoperative level.4,8 Patients were considered
fit for discharge, or functionally recovered, on the postoperative
day when all four criteria were met. Patients were discharged if all
four criteria were met and if they were willing to go home.4 A
discharge that occurred later than functional recovery was defined
as a delayed discharge.
Primary outcome was total length of hospital stay (LOS),
defined as the number of nights spent in hospital after surgery,
including nights after readmission within 90 days of surgery. Sec-
ondary outcomes were functional recovery, complications, con-
versions, blood loss and length of operation. In addition, the
following data were recorded: preoperative indication(s) for
surgery; perioperative blood transfusions; use of nasogastric
tubes; use of drains; restart of oral fluids; restart of oral solid food;
histology of the resected liver specimen, and diameter of the
lesions and resection margins.
Complications were defined according to the grading system
devised by Clavien et al.12 Grade I complications are generally
non-life-threatening complications without lasting disability.
Grade II complications are potentially life-threatening, but
without residual disability. Grade III complications involve
residual disability, including organ resections or persistence of
life-threatening conditions. Grade IV complications refer to
deaths as a result of complications.
All laparoscopic hepatic resections were performed by two con-
sultant surgeons, one expert in hepatobiliary surgery and one with
specific expertise in advanced laparoscopic surgery. Patients were
placed in the ‘French’ position (supine position with legs apart)
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under general anaesthesia.The surgeon stoodbetween the legswith
an assistant on each side.13 Liver resections were defined according
to anatomical planes (Couinaud’s classification). An open intro-
duction of the subumbilical port was used to produce the CO2
pneumoperitoneum. In all cases, a 30-degree laparoscope was
used and abdominal pressure was monitored and maintained at
12–14 mmHg. Three to four extra trocars were placed in a semi-
circle, slightly higher and paramedian of the umbilical trocar, to
facilitate the procedure.13 Inspection of the liver was performed
both visually andwith laparoscopic ultrasound in order to confirm
the number of lesions in relation to main anatomical structures.
The falciform, left triangular ligament and lesser omentum were
divided. Hepatic transection of the parenchyma and minor cross-
ing vessels and biliary radicals was performed with a harmonic
scalpel (Ultracision; Ethicon Endo-Surgery, Johnson & Johnson,
Piscataway, NJ, USA). A vascular stapler (EndoGIA; Covidien Sur-
gical Devices, New Haven, CT, USA) was used to divide the portal
pedicles and hepatic veins. Resected specimens were placed in a
plastic bag (Endocatch; Covidien Surgical Devices) and removed
through a separate, preferably suprapubic, incision. In cases where
a laparotomy had been performed in the past, a small subumbilical
incision was made for retrieval of the specimen.
Statistical analysis
Continuous variables are expressed as median (range). Age,
tumour diameter, hospital stay, functional recovery, delay in dis-
charge, blood loss and duration of surgery were analysed using the
Mann–Whitney U-test. Sex, American Society of Anesthesiolo-
gists (ASA) classification, indication for surgery, type of resection,
liver pathology, complications, conversions, intake of fluid and
solid food and the use of nasogastric tubes and drains were analy-
sed using the chi-squared or Fisher’s exact test as appropriate. A
P-value <0.05 was considered statistically significant. Data were
analysed using spss Version 13.0 for Windows (SPSS, Inc.,
Chicago, IL, USA).
Results
A total of 26 patients were treated by laparoscopic liver resection
during the 5-year period in the four participating hospitals. Thir-
teen patients were treated by laparoscopic liver resections (left
lateral sectionectomy [II, III] or segmentectomy [IV, V, VI] under
the ERAS programme (group 1). All of these were operated at a
single centre (MUMC). Thirteen patients were operated in tradi-
tional perioperative care settings in the four participating hospi-
tals during the same period (group 2). Three laparoscopic
procedures were performed atMUMC from 2003–2005 before the
ERAS programme was instituted. Ten patients were operated lap-
aroscopically in traditional perioperative care settings at the AMC
(n = 4), UMCU (n = 2) and UMCG (n = 4).
Demographics and clinical data are reported in Table 1.Median
total LOS was reduced by 2 days in the ERAS group, but this
difference did not attain statistical significance (Table 2). There
were no readmissions in either group. There were two minor
complications (grade I) in the ERAS group and two (grade I) in
the traditional care group. In group 1, one patient had a urinary
tract infection, which was treated by antibiotics, and another had
constipation and remained in hospital longer. In group 2, one
patient was treated for a hypokalaemia and another for atrial
fibrillation. There were no deaths. The rate of conversions was
similar in both groups (Table 2). In group 2 (traditional care),
conversion occurred because of a preoperatively undetected lesion
in segment IV in one patient and suboptimal visualization in
another. The conversions in the ERAS group occurred because of
the uncertain nature and size of the lesion and its proximity to the
Table 1 Clinical and pathological features
Group 1 Group 2 P-value
ERAS programme Traditional care
(n = 13) (n = 13)
Age, years* 55 (34–82) 45 (26–70) 0.104†
ASA score I/II/III/IV 3/9/1/0 6/6/1/0 0.688
Patient sex, M/F 3/10 2/11 1.0
Indication for surgery: malignant/benign 8/5 3/10 0.111
Types of liver resection
Left lateral sectionectomy 9 9
Monosegmentectomy (or metastasectomy) 3 3 1.0
Multiple segmentectomy (2 segments) 1 1
Liver pathology: malignant/benign 5/8 2/11 0.160
Tumour size, cm* 4.1 (1.0–10.5) 6.0 (1.4–8.0) 0.765†
*Continuous variables are expressed as median (range)
P-values by Fisher's exact test, except †Mann–Whitney U-test
ERAS, Enhanced Recovery After Surgery; ASA, American Society of Anaesthesiologists; M, male; F, female
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left liver vein in one patient and because of suboptimal visualiza-
tion in another. Blood loss was significantly less in the ERAS group
(P < 0.002). However, there was no difference in blood transfu-
sions. Only one patient from group 2 (traditional care) received
two units of packed cell while in hospital. No significant difference
was observed in operation time. Oral fluid intake was resumed
within 24 hours of surgery in almost all patients in the ERAS
group, as well as in the traditional care group (median 1 day
[range 0–2 days] vs. median 1 day [range 0–6 days], respectively;
P = 0.861). The median time to successful resumption of normal
diet was 1 day (range 1–2 days) in the ERAS group, compared with
2 days (range 1–6 days) in the controls (P = 0.223). Nasogastric
decompression tubes were not used after surgery in the ERAS
group. In the control group, nasogastric tubes were in place after
surgery in five of 13 patients for 1–5 days (P = 0.257). This
included two reinsertions because of delayed gastrointestinal
function on day 1. In the ERAS group, no drains were used after
surgery. In the control group, six patients received a drain, which
was removed 2–4 days after surgery (P = 0.015).
In both groups, functional recovery was achieved a median of 2
days earlier than actual discharge. In the ERAS group, patients met
the discharge criteria on median postoperative day 3 (range 1–7
days), compared with the traditional care group, which met the
discharge criteria onmedian postoperative day 5 (range 2–8 days).
The difference between the groups in functional recovery proved
to be statistically significant (P < 0.044), as did the difference in
delay in discharge (P < 0.032).
In group 1, resected specimens included two hepatocellular
adenomas, two focal nodular hyperplasias (FNHs), an angiomyo-
lipoma, a haemangioma, a presumed metastasis which proved to
be an inflammatory pseudotumour after chemotherapy, an intra-
hepatic accessory gallbladder with inflammation, a hepatocellular
carcinoma and four metastases of colorectal origin. Resection
margins were free of disease in 12 cases; one resected adenoma
extended to the resection margin. In group 2, resected specimens
included three adenomas, six FNHs and two haemangiomas and,
in two patients, three metastases of colorectal origin. Resection
margins were free of disease in eight patients, were not reported
(benign tumour) in four and involved a haemangioma in the
resection surface in one.
No late complications were recorded in group 1 during the
follow-up period (median 3 months, range 1–23 months). In the
follow-up period (median 6months, range 1–27months) in group
2,one patient developed colorectalmetastases in the lungs and liver
(segmentsVI andVII) and simultaneous acutemyeloid leukaemia.
No palliative chemotherapy was given to this patient because of his
clinical condition and he died 12 months postoperatively.
Discussion
This study investigated the added value of an enhanced recovery
programme in laparoscopic liver surgery. To the best of our
knowledge, this represents the first such study to be conducted
(although it is only a small pilot study). The results suggest that
initiation of a multimodal enhanced recovery programme in lap-
aroscopic liver surgery is feasible. It also shows that it is safe to
implement an evidence-based enhanced recovery programme, as
there were only two minor complications in the ERAS group and
two conversions in each group. The difference in median LOS of 2
days did not attain significance, but this probably reflects the small
number of patients in this study. Importantly, the current study
provides evidence that an enhanced recovery programme is asso-
ciated with expedited functional recovery. Patients in the laparo-
scopic ERAS group fulfilled discharge criteria 2 days earlier than
control patients.
Patients in the enhanced recovery group had less blood loss.
This may have resulted from the implementation of the ERAS
protocol, which prescribes a low CVP and the avoidance of exces-
sive perioperative fluids. However, although this outcome is
significant, it remains unclear whether it resulted solely from the
Table 2 Primary and secondary outcomes. No readmissions were recorded in either group
Group 1 Group 2 P-value
ERAS programme Traditional care
(n = 13) (n = 13)
Primary outcome
Total LOS, days* 5.0 (3–10) 7.0 (3–12) 0.305†
Secondary outcomes
Functional recovery, days* 3 (1–7) 5 (2–8) 0.044†
Complications, n (grade) 2 (I) 2 (I) 1.0
Conversions, n 2 2 1.0
Blood loss, ml* 50 (50–200) 250 (50–800) 0.002†
Operation time, min* 118 (85–192) 180 (51–340) 0.293†
*Continuous variables are expressed as median (range)
P-values by Fisher's exact test, except †Mann–Whitney U-test
ERAS, Enhanced Recovery After Surgery; LOS, length of stay
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implementation of ERAS. This difference in blood loss may also
have been clouded by the learning curve effect because the
patients operated in group 2 (traditional care) were the first
patients to be treated laparoscopically in the participating centres.
Most authors recommend that laparoscopic procedures on liver
resections of solid tumours should preferably begin with the left
lateral segments or anterolateral small lesions of the right side.13,14
Tumours of the left lateral side, particularly benign tumours, con-
stitute only a small fraction of the minor resections in most units.
This is probably one of the reasons for the small number of patients
in this pilot study. It was also considered unethical to prospectively
compare effects in an intervention (ERAS) group with effects in a
control group receiving traditional care in Maastricht because the
ERAS protocol includes several evidence-based care elements
aimed at reducing surgical stress and postoperative catabolism.6–8
Studies on colorectal laparoscopy and fast-track programmes
have shown conflicting results regarding the additional outcomes
of minimally invasive surgery performed within a perioperative
ERAS programme. In a single-centre study, the laparoscopic
approach seemed to improve the outcome in terms of LOS,
whereas other studies, including a randomized controlled trial,
showed no additional effect of laparoscopy on LOS.15–17 Therefore,
it has been suggested that there is a need for further randomized
trials to evaluate the additional effects of laparoscopy within fast-
track recovery programmes in colorectal surgery.5,15,16 At present,
there is only limited evidence available about the effects on LOS of
a multimodal, fast-track setting in liver surgery.4
In the current study, a difference between the date of functional
recovery of patients undergoing liver resection and the day of
actual discharge was observed, as we previously reported in a
colonic ERAS programme.11 A significant difference of a median
of 2 days in time to full functional recovery was observed between
the ERAS-treated group and the traditional care group. It is
remarkable that, despite the preoperative counselling in the ERAS
programme, a difference between functional recovery and actual
day of discharge was still observed. This implies that the difference
in LOS may be even more pronounced if patients do actually go
home as soon as they are functionally recovered according to
predefined criteria.8,11 Delay in discharge and presence of compli-
cations were associated with increased LOS. For future studies,
functional recovery may be a better criterion with which to inves-
tigate differences in outcome of surgical treatments. Establishing
the effect of ERAS programmes on outcomes in laparoscopic liver
surgery in a more structured manner is a challenge yet to be met.
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